| 产品名称： | Lysinibacillus sphaericus |
|---|---|
| 商品货号： | TS183829 |
| Deposited As： | Bacillus lentus Gibson |
| Strain Designations： | MB 284 |
| Application： | Hydroxylates sclareol Produces 1,4-diene-3-ketosteroids Transforms isopinocampheol |
| Isolation： | Soil |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Comments： | Uv-induced mutant |
| Medium： | ATCC® Medium 225: Beef extract medium |
| Growth Conditions： | Temperature: 37.0°C |
| Name of Depositor： | Schering, Inc. |
| U.S. Patent Number： | |
| References： | Raspe G, et al. Method of producing 1,4-diene-3-ketosteroids. US Patent 3,102,080 dated Aug 27 1963 Z. Naturforsch. Sect. C Biosci. 49: 553-560, 1994. Wolf-Rainer A. Microbial hydroxylation of sclareol. Phytochemistry 36: 1421-1424, 1994. Ahmed I, et al. Proposal of Lysinibacillus boronitolerans gen. nov. sp. nov., and transfer of Bacillus fusiformis to Lysinibacillus fusiformis comb. nov. and Bacillus sphaericus to Lysinibacillus sphaericus comb. nov. Int. J. Syst. Evol. Microbiol. 57(Pt 5): 1117-1125, 2007. PubMed: 17473269 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Lysinibacillus sphaericus |
|---|---|
| 商品货号： | TS183829 |
| Deposited As： | Bacillus lentus Gibson |
| Strain Designations： | MB 284 |
| Application： | Hydroxylates sclareol Produces 1,4-diene-3-ketosteroids Transforms isopinocampheol |
| Isolation： | Soil |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Comments： | Uv-induced mutant |
| Medium： | ATCC® Medium 225: Beef extract medium |
| Growth Conditions： | Temperature: 37.0°C |
| Name of Depositor： | Schering, Inc. |
| U.S. Patent Number： | |
| References： | Raspe G, et al. Method of producing 1,4-diene-3-ketosteroids. US Patent 3,102,080 dated Aug 27 1963 Z. Naturforsch. Sect. C Biosci. 49: 553-560, 1994. Wolf-Rainer A. Microbial hydroxylation of sclareol. Phytochemistry 36: 1421-1424, 1994. Ahmed I, et al. Proposal of Lysinibacillus boronitolerans gen. nov. sp. nov., and transfer of Bacillus fusiformis to Lysinibacillus fusiformis comb. nov. and Bacillus sphaericus to Lysinibacillus sphaericus comb. nov. Int. J. Syst. Evol. Microbiol. 57(Pt 5): 1117-1125, 2007. PubMed: 17473269 |
